Appeals Court Revives Hundreds of Diabetes Drug Lawsuits
A federal appeals court has revived more than 750 lawsuits filed over four diabetes drugs after finding that a San Diego judge misapplied a 2011 U.S. Supreme Court opinion relating to federal pre-emption.
December 11, 2017 at 05:53 PM
8 minute read
David Frederick. Photo: Diego M. Radzinschi/ALM
A federal appeals court has revived more than 750 lawsuits filed over four diabetes drugs after finding that a San Diego judge misapplied a 2011 U.S. Supreme Court opinion relating to federal pre-emption.
In a Dec. 6 unpublished memorandum, the U.S. Court of Appeals for the Ninth Circuit punted on a key issue in the case: whether the manufacturers of the drugs, under the Supreme Court's 2009 holding in Wyeth v. Levine, could provide “clear evidence” that the Food and Drug Administration would “not have approved” changes to the drugs' labeling that plaintiffs alleged were necessary to warn of links to pancreatic cancer.
Kannon Shanmugam, a Washington, D.C., partner at Williams & Connolly who argued for the drug manufacturers, had insisted the makers of the drugs had done extensive research to disprove such a link.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Trending Stories
- 1Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 2The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 3The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5'You Are Not Alone': 120 Sex Assault Victims Plan to Sue Sean 'Diddy' Combs
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250